JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB179800

Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012]

  • KO Validated
  • RabMAb
  • Recombinant
  • Lab Essentials
  • 20ul selling size
  • What is this?

4

(3 Reviews)

|

(282 Publications)

Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (ab179800) is a rabbit monoclonal antibody detecting COX2 / Cyclooxygenase 2 in Western Blot, IP, IHC-P, ICC/IF. Suitable for Human, Mouse, Rat.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 120 publications

View Alternative Names

COX2, PTGS2, Prostaglandin G/H synthase 2, Cyclooxygenase-2, PHS II, Prostaglandin H2 synthase 2, Prostaglandin-endoperoxide synthase 2, COX-2, PGH synthase 2, PGHS-2

17 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of mouse kidney tissue sections labeling COX2 / Cyclooxygenase 2 with purified ab179800 at 1/4000 dilution (0.125 µg/ml).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins. Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used as the secondary antibody. Negative control : secondary antibody only control. Hematoxylin was used as a counterstain.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded) analysis of human liver tissue labelling COX2 / Cyclooxygenase 2 with unpurified ab179800 at a dilution of 1/250.

Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Immunocytochemistry/ Immunofluorescence - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)

Immunocytochemistry/ Immunofluorescence analysis of U-87 MG (human glioblastoma-astrocytoma epithelial cell) cells labeling COX2 / Cyclooxygenase 2 with ab179800 at 1/50 dilution. ab150077 (AlexaFluor®488 Goat anti-Rabbit) at 1/1000 was used as secondary antibody. Cells were fixed with 4% Paraformaldehyde and permeabilised with 0.1% TritonX-100. ab195889, Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) at 1/200 was used as counterstain. Nuclie were stained blue with DAPI.

Confocal image showing cytoplasmic staining in U-87 MG cell line.
Negative control : MCF7 (PMID : 18199541)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded) analysis of human colon tissue labeling COX2 / Cyclooxygenase 2 with unpurified ab179800 at a dilution of 1/250.

Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human colonic carcinoma tissue labelling COX2 / Cyclooxygenase 2 with unpurified ab179800 at a dilution of 1/250.

Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human lung carcinoma tissue labelling COX2 / Cyclooxygenase 2 with purified ab179800 at 1/100. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. ab97051, a HRP-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/500). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)

Immunohistochemical analysis of formalin fixed paraffin embedded human colon labelling COX2/ Cyclooxygenase 2 with ab179800 at a concentration of 0.01µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins.

ab179800 Anti-COX2/Cyclooxygenase 2 antibody [EPR12012] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.

Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).

Immunoprecipitation - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)
  • IP

Supplier Data

Immunoprecipitation - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)

Western blot analysis on immunoprecipitation pellet from A549 cell lysate using unpurified ab179800.

All lanes:

Immunoprecipitation - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (ab179800)

Predicted band size: 69 kDa

false

Immunoprecipitation - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)
  • IP

Lab

Immunoprecipitation - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)

ab179800 (purified) at 1/30 immunoprecipitating COX2 in A549 whole cell lysate.

Lane 1 (input) : A549 whole cell lysate (10μg)

Lane 2 (+) : ab179800 + A549 whole cell lysate.

Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab179800 in A549 whole cell lysate.

For western blotting, HRP-conjugated anti-rabbit IgG, specific for the reduced form of IgG, was used as the secondary antibody (1/1500).

Blocking buffer and concentration : 5% NFDM/TBST.

Diluting buffer and concentration : 5% NFDM /TBST.

All lanes:

Immunoprecipitation - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (ab179800)

Predicted band size: 69 kDa

Observed band size: 79 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of mouse liver tissue sections labeling COX2 / Cyclooxygenase 2 with purified ab179800 at 1/4000 dilution (0.125 µg/ml).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins. Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used as the secondary antibody. Negative control : secondary antibody only control. Hematoxylin was used as a counterstain.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of rat kidney tissue labelling COX2 / Cyclooxygenase 2 with purified ab179800 at 1/100. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. ab97051, a HRP-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/500). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.

Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)
  • WB

Lab

Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)

Compared with ab179800, ab283574 has higher sensitivity, we recommend ab283574 as an alternative for testing COX2 in western blot.

ab181602 was used as a loading control at a 1/1000000 dilution.

Blocking and dilution buffer : 5% NFDM/TBST.

Lanes 1 - 3:

Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (ab179800) at 1/1000 dilution

Lanes 4 - 6:

Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [RM1026] (<a href='/en-us/products/primary-antibodies/cox2-cyclooxygenase-2-antibody-rm1026-ab283574'>ab283574</a>) at 1/1000 dilution

Lanes 1 and 3:

Wild-type HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg

Lanes 2 and 4:

PTGS2 knockout HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg

Lanes 3 and 6:

A549 (Human lung carcinoma epithelial cell) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 69 kDa

Observed band size: 75 kDa

false

Exposure time: 180s

Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)
  • WB

Lab

Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)

Exposure time : lane 1 : 180 seconds, lane 2 : 140 seconds. We recommend using a higher sensitive ECL substrate to increase the band intensity

All lanes:

Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (ab179800) at 1/1000 dilution

All lanes:

A549 (Human lung carcinoma epithelial cell) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

false

Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)
  • WB

Lab

Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)

False colour image of Western blot : Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab179800 was shown to bind specifically to COX2 / Cyclooxygenase 2. A band was observed at 75 kDa in wild-type A549 cell lysates with no signal observed at this size in PTGS2 knockout cell line ab280802 (knockout cell lysate ab283825). To generate this image, wild-type and PTGS2 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (ab179800) at 1/1000 dilution

Lane 1:

Wild-type A549 cell lysate at 20 µg

Lane 2:

PTGS2 knockout A549 cell lysate at 20 µg

Lane 2:

Western blot - Human PTGS2 (COX2 / Cyclooxygenase 2) knockout A549 cell line (<a href='/en-us/products/cell-lines/human-ptgs2-cox2-cyclooxygenase-2-knockout-a549-cell-line-ab280802'>ab280802</a>)

Lane 3:

U-87 MG cell lysate at 20 µg

Lane 4:

MOLT-4 cell lysate at 20 µg

Predicted band size: 69 kDa

false

Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)
  • WB

Lab

Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)

Western blot : Anti-PTGS2 antibody [EPR12012] (ab179800) staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab179800 was shown to bind specifically to PTGS2. A band was observed at 69 kDa in wild-type RAW 264.7 cell lysates with no signal observed at this size in PTGS2 knockout cell line. To generate this image, wild-type and PTGS2 knockout RAW 264.7 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

Lanes 1 - 4:

Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (ab179800) at 1/1000 dilution

Lanes 1 - 4:

Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] - BSA and Azide free (<a href='/en-us/products/primary-antibodies/cox2-cyclooxygenase-2-antibody-epr12012-bsa-and-azide-free-ab227528'>ab227528</a>)

Lane 1:

RAW 264.7 Control LPS (0 ng/mL, 4 h) cell lysate at 20 µg

Lane 2:

RAW 264.7 Treated LPS (100 ng/mL, 4 h) cell lysate at 20 µg

Lane 3:

Wild-type A549 ab277305 cell lysate at 20 µg

Lane 4:

PTGS2 knockout A549 ab283802 cell lysate at 20 µg

Observed band size: 69 kDa

false

Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)
  • WB

Lab

Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)

Blocking buffer and concentration : 5% NFDM/TBST  Diluting buffer and concentration : 5% NFDM/TBST COX2 is expressed at a low level in Raw264.7, mouse retina, hippocampus, heart, kidney etc. (PMID : 22015457, PMID : 26001832, PMID : 23045674, PMID : 33737575). The WB is using a higher sensitivity ECL substrate.

All lanes:

Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (ab179800) at 1/1000 dilution

Lane 1:

B16-F10 (Mouse skin melanoma) whole cell lysate at 20 µg

Lane 2:

Raw 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg

Lane 3:

Mouse retina tissue lysate at 20 µg

Lane 4:

Mouse hippocampus tissue lysate at 20 µg

Lane 5:

Mouse heart tissue lysate at 20 µg

Lane 6:

Mouse kidney tissue lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 69 kDa

Observed band size: 72 kDa

false

Exposure time: 60s

Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)
  • WB

CiteAb

Western blot - Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (AB179800)

COX2 / Cyclooxygenase 2 western blot using anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] ab179800. Publication image and figure legend from Zhang, C., Ning, D., et al., 2021, Mediators Inflamm, PubMed 33776576.

ab179800 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab179800 please see the product overview.

Effect of EFBS on LPS-induced COX2, iNOS, and NF-κB p65 expression in lung tissue. The ICR mice were left untreated or challenged with LPS (5 mg/kg) for 6 h following no pretreatment or preadministration of 5 mg/kg DEX, 20 mg/kg EFBS, or 60 mg/kg EFBS. All mice were sacrificed 6 h after LPS administration, and lung tissue was collected for western blot analysis with specific antibodies. Data are expressed as mean ± SD (n = 3). *p < 0.05, **p < 0.01 compared with the vehicle treatment group. #p < 0.05, ##p < 0.01 compared with the DEX treatment group.

false

  • Carrier free

    Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] - BSA and Azide free

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012]

  • 603 Alexa Fluor® 568

    Alexa Fluor® 568 Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012]

  • 775 Alexa Fluor® 750

    Alexa Fluor® 750 Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012]

  • Biotin

    Biotin Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR12012

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

IHC-P, ICC/IF, IP, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

Stimulation is required to allow detection of the COX2 protein in some cell lines and tissues. It is better to use a positive control side by side when testing.

Rat species is recommended based on IHC result, we do not guarantee WB, IP and ICC/IF for Rat.

For western blot application, this antibody has low sensitivity issue. We suggest optimizing experimental protocols (increasing lysate amount, using lower antibody dilution or higher sensitivity ECL substrate) to improve results. We also recommend ab283574 as an alternative for testing COX2 in western blot.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/10 - 1/100", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p>For western blot application, this antibody has low sensitivity issue. We suggest optimizing experimental protocols (increasing lysate amount, using lower antibody dilution or higher sensitivity ECL substrate) to improve results. We also recommend <a href='/en-us/products/primary-antibodies/cox2-cyclooxygenase-2-antibody-rm1026-ab283574'>ab283574</a> as an alternative for testing COX2 in western blot.</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/4000", "IHCP-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p>For western blot application, this antibody has low sensitivity issue. We suggest optimizing experimental protocols (increasing lysate amount, using lower antibody dilution or higher sensitivity ECL substrate) to improve results. We also recommend <a href='/en-us/products/primary-antibodies/cox2-cyclooxygenase-2-antibody-rm1026-ab283574'>ab283574</a> as an alternative for testing COX2 in western blot.</p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/4000", "IHCP-species-notes": "<p></p>" }, "Rat": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "<p>For western blot application, this antibody has low sensitivity issue. We suggest optimizing experimental protocols (increasing lysate amount, using lower antibody dilution or higher sensitivity ECL substrate) to improve results. We also recommend <a href='/en-us/products/primary-antibodies/cox2-cyclooxygenase-2-antibody-rm1026-ab283574'>ab283574</a> as an alternative for testing COX2 in western blot.</p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/4000", "IHCP-species-notes": "<p></p>" } } }

Product details

Product Specifications

Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (ab179800) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in ICC/IF, IHC-P, IP, WB in human, mouse, rat samples.
Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (ab179800) specifically detects COX2 / Cyclooxygenase 2 (UniProt ID: P35354; Molecular weight: 67kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL).

Quality and Validation

Abcam's high quality manufacturing and validation processes ensure Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (ab179800) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
The specificity of Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (ab179800) has been confirmed by testing in knockout samples.
Anti-COX2 / Cyclooxygenase 2 antibody [EPR12012] (ab179800) has been cited over 127 times in peer reviewed journals and is trusted by the scientific community.

Related Products
Conjugation-ready, carrier free format available for antibody clone EPR12012 - ab227528.
Antibody clone EPR12012 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 647, Alexa Fluor® 488, Alexa Fluor® 594, Alexa Fluor® 568, Alexa Fluor® 555, Alexa Fluor® 750, Biotin (ab225273, ab310991, ab311743, ab313023, ab313225, ab321225, ab322299).
Target Information
Cyclooxygenase-2 (COX-2) is an enzyme crucial for the inflammatory response, as it converts arachidonic acid into prostaglandins that mediate inflammation and pain. It is involved in various diseases, such as cancer, cardiovascular diseases, and neurodegenerative disorders, due to its role in promoting inflammation and tumor growth.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Cyclooxygenase 2 also known as COX2 is an enzyme involved in the conversion of arachidonic acid to prostaglandins which are lipid compounds with hormone-like effects. It has alternative names including prostaglandin-endoperoxide synthase 2. The molecular weight of COX2 is approximately 72 kDa. This enzyme is expressed in various tissues including the brain kidneys and areas of inflammation. COX2 expression increases during inflammatory responses and is induced by pro-inflammatory cytokines.
Biological function summary

COX2 plays a significant role in the inflammatory response and is part of the complex process of synthesizing prostaglandins. These compounds mediate inflammation and pain making COX2 an important target for understanding these processes. COX2 is not ubiquitously expressed but rather is induced in activated macrophages and other cells during inflammatory conditions. Its function is also important for normal physiological processes like ovulation and implantation.

Pathways

COX2 is essential in the prostaglandin biosynthesis pathway connecting it to the arachidonic acid metabolism pathway. Cyclooxygenase 2 works with phospholipase A2 which releases arachidonic acid from the phospholipid membrane. COX2 then converts this acid to prostaglandin H2 a precursor for other prostaglandins. COX1 the other isoform of cyclooxygenase is closely related to COX2 and while they have different expression patterns they share some functional similarities in these pathways.

COX2 is connected to inflammatory conditions like arthritis and cancer. Its expression often increases in various cancer types contributing to tumor growth and metastasis by promoting angiogenesis and suppressing immune responses. The enzyme is also linked to rheumatoid arthritis where its overexpression exacerbates inflammation. COX2 inhibitors like ketorolac tromethamine or naproxen structure mitigate symptoms by decreasing prostaglandin synthesis. These inhibitors also interact with COX1 but selective inhibition of COX2 targets inflammation more effectively with fewer gastric side effects associated with COX1 inhibition.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Dual cyclooxygenase and peroxidase in the biosynthesis pathway of prostanoids, a class of C20 oxylipins mainly derived from arachidonate ((5Z,8Z,11Z,14Z)-eicosatetraenoate, AA, C20 : 4(n-6)), with a particular role in the inflammatory response (PubMed : 11939906, PubMed : 16373578, PubMed : 19540099, PubMed : 22942274, PubMed : 26859324, PubMed : 27226593, PubMed : 7592599, PubMed : 7947975, PubMed : 9261177). The cyclooxygenase activity oxygenates AA to the hydroperoxy endoperoxide prostaglandin G2 (PGG2), and the peroxidase activity reduces PGG2 to the hydroxy endoperoxide prostaglandin H2 (PGH2), the precursor of all 2-series prostaglandins and thromboxanes (PubMed : 16373578, PubMed : 22942274, PubMed : 26859324, PubMed : 27226593, PubMed : 7592599, PubMed : 7947975, PubMed : 9261177). This complex transformation is initiated by abstraction of hydrogen at carbon 13 (with S-stereochemistry), followed by insertion of molecular O2 to form the endoperoxide bridge between carbon 9 and 11 that defines prostaglandins. The insertion of a second molecule of O2 (bis-oxygenase activity) yields a hydroperoxy group in PGG2 that is then reduced to PGH2 by two electrons (PubMed : 16373578, PubMed : 22942274, PubMed : 26859324, PubMed : 27226593, PubMed : 7592599, PubMed : 7947975, PubMed : 9261177). Similarly catalyzes successive cyclooxygenation and peroxidation of dihomo-gamma-linoleate (DGLA, C20 : 3(n-6)) and eicosapentaenoate (EPA, C20 : 5(n-3)) to corresponding PGH1 and PGH3, the precursors of 1- and 3-series prostaglandins (PubMed : 11939906, PubMed : 19540099). In an alternative pathway of prostanoid biosynthesis, converts 2-arachidonoyl lysophopholipids to prostanoid lysophopholipids, which are then hydrolyzed by intracellular phospholipases to release free prostanoids (PubMed : 27642067). Metabolizes 2-arachidonoyl glycerol yielding the glyceryl ester of PGH2, a process that can contribute to pain response (PubMed : 22942274). Generates lipid mediators from n-3 and n-6 polyunsaturated fatty acids (PUFAs) via a lipoxygenase-type mechanism. Oxygenates PUFAs to hydroperoxy compounds and then reduces them to corresponding alcohols (PubMed : 11034610, PubMed : 11192938, PubMed : 9048568, PubMed : 9261177). Plays a role in the generation of resolution phase interaction products (resolvins) during both sterile and infectious inflammation (PubMed : 12391014). Metabolizes docosahexaenoate (DHA, C22 : 6(n-3)) to 17R-HDHA, a precursor of the D-series resolvins (RvDs) (PubMed : 12391014). As a component of the biosynthetic pathway of E-series resolvins (RvEs), converts eicosapentaenoate (EPA, C20 : 5(n-3)) primarily to 18S-HEPE that is further metabolized by ALOX5 and LTA4H to generate 18S-RvE1 and 18S-RvE2 (PubMed : 21206090). In vascular endothelial cells, converts docosapentaenoate (DPA, C22 : 5(n-3)) to 13R-HDPA, a precursor for 13-series resolvins (RvTs) shown to activate macrophage phagocytosis during bacterial infection (PubMed : 26236990). In activated leukocytes, contributes to oxygenation of hydroxyeicosatetraenoates (HETE) to diHETES (5,15-diHETE and 5,11-diHETE) (PubMed : 22068350, PubMed : 26282205). Can also use linoleate (LA, (9Z,12Z)-octadecadienoate, C18 : 2(n-6)) as substrate and produce hydroxyoctadecadienoates (HODEs) in a regio- and stereospecific manner, being (9R)-HODE ((9R)-hydroxy-(10E,12Z)-octadecadienoate) and (13S)-HODE ((13S)-hydroxy-(9Z,11E)-octadecadienoate) its major products (By similarity). During neuroinflammation, plays a role in neuronal secretion of specialized preresolving mediators (SPMs) 15R-lipoxin A4 that regulates phagocytic microglia (By similarity).
See full target information PTGS2

Publications (282)

Recent publications for all applications. Explore the full list and refine your search

The journal of headache and pain 26:197 PubMed41039196

2025

Inhibition of the METTL3/mA/miR-34a-5p axis suppresses trigeminovascular activation in nitroglycerin-induced migraine via the Wnt/β-catenin pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Hui Zhang,Minming Shao,Feng Zhang,Caiyan He,Jiabi Li,Shengdong He

Cells 14: PubMed40801649

2025

When Two Worlds Collide: The Contribution and Association Between Genetics (APOEε4) and Neuroinflammation (IL-1β) in Alzheimer's Neuropathogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Jagadeesh Narasimhappagari,Ling Liu,Meenakshisundaram Balasubramaniam,Srinivas Ayyadevara,W Sue T Griffin

Journal of cellular and molecular medicine 29:e70772 PubMed40785041

2025

Tianma Granules Alleviate AOM/DSS-Induced Colorectal Tumorigenesis by Inhibiting the Wnt/β-Catenin Pathway Activation.

Applications

Unspecified application

Species

Unspecified reactive species

Renjing Lin,Jinyin Xiao,Yanjie Chen,Xu Li,Peiwen Zhang,Runcheng Zhang,Min Luo

Histology and histopathology :18968 PubMed40740145

2025

Mechanism of the protective effect of 2,3,5,4'-Tetrahydroxy stilbene-2-O-β-D-glucoside on MPTP-induced Parkinson's disease mice.

Applications

Unspecified application

Species

Unspecified reactive species

Gang Wu,Xiaolin Dong,Qingyun Li,Yanping Li,Furong Jin,Jingting Lu,Chengda Han,Lianbing Lin

Scientific reports 15:27037 PubMed40715217

2025

Biotin/sulfasalazine combination therapy alleviates acetic acid-induced ulcerative colitis in rats via modulation of S1PR1/NF-κB/IL-23/STAT3/COX-2 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Sahar A Helmy,Mahmoud M Samaha,Al Shaima G Abd El Salam,Nesma A Abd Elrazik

Behavioral and brain functions : BBF 21:25 PubMed40713782

2025

C18:0 GM3 ganglioside's efficacy in LPS-induced parkinsonism: neuroprotection, inflammatory inhibition and gliosis mitigation.

Applications

Unspecified application

Species

Unspecified reactive species

Tsung-Ta Liu,Cheng-Tsung Liu,I-Hsun Li,Yu-Chieh Chu,Hao-Yuan Hung,Chuang-Hsin Chiu,Ta-Kai Chou,Shiao-Yun Li,Tin-An Wang,Jui-Hu Shih

Molecular medicine (Cambridge, Mass.) 31:258 PubMed40681992

2025

FXR acts as a therapeutic target for ulcerative colitis via suppressing ferroptosis.

Applications

Unspecified application

Species

Unspecified reactive species

Chenye Zhao,Xiaopeng Li,Mingchao Mu,Liyong Quan,Hang Yuan,Jianbao Zheng,Wei Zhao,Xuejun Sun,Junhui Yu

Frontiers in immunology 16:1538046 PubMed40547034

2025

Wharton's jelly-derived mesenchymal stem cells ameliorate high altitude-induced heart injury by promoting type 2 macrophage polarization via COX2-PGE2 pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Wenhong Zhang,Li Zhao,Jing Cui,Yan Zhang,Dongtao Li,Zhibo Hong,Jiamin Liu,Shan Wang,Ningkun Zhang,Yang Li,Yu Chen

Journal of translational medicine 23:661 PubMed40528192

2025

The pasteurized Weissella cibaria alleviates sepsis-induced acute lung injury by modulation of intestinal mucus barrier and gut microbiota.

Applications

Unspecified application

Species

Unspecified reactive species

Yuanzhe Li,Debin Yang,Huan Zhao,Liping Dou,Qian Chen,Yibing Cheng,Bo Hu,Yu Tang,Yongtao Duan,Caili Guo,Abbas Sakandar,Dong Li

Materials today. Bio 32:101897 PubMed40502369

2025

GM@mTG-V microspheres promote NP regeneration by reconstructing IVD biomechanics and inflammatory microenvironment.

Applications

Unspecified application

Species

Unspecified reactive species

Rong Gao,Yongfeng Zhang,Bo Deng,Jiawei Zhang,Zhuowen Liang,Zhao Wei,Feng Xu,Tan Ding
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com